|
Stadastrasse 2-18 D-61118 Bad Vilbel, Germany Tel. +49-6101-603-0 Fax +49-6101-603-259 |
Type: Public
On the web:
http://www.stada.de
STADA Arzneimittel is right in the middle of the European pharmaceutical industry. The German company produces generic and brand-name drugs, as well as specialty pharmaceuticals. STADA's largest segment is its generic drugs business, which makes the company's best-selling product, stomach medication Omeprazol. The tummy remedy is only available in Germany. Its branded products include OTC and self-medications, and the company's specialty pharmaceuticals include vaccines, sold under the Eurovax brand, and cancer treatment drugs. STADA is expanding its sales further into Asia and is entering the US market.
Key numbers for fiscal year ending December, 2007:
Sales: $4,521.2M
One year growth: 40.7%
Net income: $302.7M
Income growth: 27.7%
Officers:
Chairman, Supervisory Board: Eckhard Brüggemann
Chairman, Executive Board and CEO: Hartmut Retzlaff
CFO: Wolfgang Jeblonski
Competitors:
Johnson & Johnson
Merck KGaA
Roche Holding




